• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可穿戴技术在痴呆症致病疾病早期检测中的可接受性:CODEC II队列研究的观点

Acceptability of wearable technology for the early detection of dementia-causing diseases: perspectives from the CODEC II cohort.

作者信息

Wilson Sarah, Beswick Emily, Morrell Rachel, Bhogal Sharandeep, Tolley Clare, Whitfield Tim, Wing Kieran, Mc Ardle Riona, Hassan Nehal, Walker Zuzana, Slight Sarah

机构信息

School of Pharmacy, Newcastle University, King George VI Building, Queen Victoria Road, Newcastle Upon Tyne, UK.

Trinity College Dublin, Dublin, Ireland.

出版信息

BMC Digit Health. 2025;3(1):55. doi: 10.1186/s44247-025-00191-3. Epub 2025 Aug 29.

DOI:10.1186/s44247-025-00191-3
PMID:40893385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12394386/
Abstract

BACKGROUND

The global prevalence of dementia is increasing exponentially. Early detection of dementia-causing diseases could support therapeutic intervention to decelerate disease progression. Wearable digital technologies can be used to identify early signs of such diseases and remotely monitor disease progression. However, technologies must be acceptable to users. This study explored the perspectives of participants on the acceptability of various wearable technologies for early detection.

METHOD

Participants from the Cognitive Decline using Digital Devices (CODEC-II) cohort used four different wearables (smartwatch, electroencephalographic [EEG] headband, active and passive smartphone apps) for two weeks every three months over a year. A subgroup participated in semi structured interviews after two weeks to discuss their experiences and acceptance of the devices. Data was analysed using the framework analysis approach, aided by N-Vivo (v14.23.2).

RESULTS

Twenty-one participants were interviewed, including individuals with subjective cognitive decline ( = 10), mild cognitive impairment (MCI) ( = 7), dementia with Lewy bodies ( = 1), and three caregivers. Five key themes were identified, including ease of use, wearability, usefulness, transparency, and behavioral intention. Many participants relied on the research team to help set up the technology for them due to high levels of digital anxiety. Individuals with MCI particularly struggled with cognitive testing games in the active smartphone app, which they experienced increased awareness of their own cognitive impairments. Participants preferred wrist-worn over head-worn devices due to familiarity and impact on their appearance. While some participants enjoyed using the wearables, others questioned their accuracy for medical purposes. There was also a lack of understanding around what data were being collected from the wearables and how it was being collected, with some expressing concerns about data disclosure. Participants with professional or caregiving responsibilities described how their busy lifestyles hindered daily use of the wearables.

CONCLUSION

These findings highlight the importance of using an inclusive design approach to meet users' needs and support digital inclusivity, and an effective communication strategy to increase transparency and reduce data disclosure concerns. Future research is needed to explore the effectiveness of implementing current recommendations to support digital health equity and codesign a communication strategy with users to ensure the information is understandable.

TRIAL REGISTRATION

CODEC-II was retrospectively registered as a clinical trial under the registry ClinicalTrials.gov (trial registration number: NCT07051408, date of registration: 3rd June 2025).

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1186/s44247-025-00191-3.

摘要

背景

全球痴呆症患病率呈指数级增长。早期发现导致痴呆症的疾病有助于进行治疗干预,以减缓疾病进展。可穿戴数字技术可用于识别此类疾病的早期迹象,并远程监测疾病进展。然而,技术必须为用户所接受。本研究探讨了参与者对各种可穿戴技术用于早期检测的可接受性的看法。

方法

来自使用数字设备认知衰退(CODEC-II)队列的参与者在一年时间里,每三个月使用四种不同的可穿戴设备(智能手表、脑电图[EEG]头带、主动和被动智能手机应用程序)两周。一个亚组在两周后参加了半结构化访谈,讨论他们对这些设备的体验和接受程度。数据采用框架分析方法进行分析,并借助N-Vivo(v14.23.2)软件。

结果

采访了21名参与者,包括主观认知衰退者(n = 10)、轻度认知障碍(MCI)者(n = 7)、路易体痴呆患者(n = 1)以及三名护理人员。确定了五个关键主题,包括易用性、可穿戴性、有用性、透明度和行为意向。由于高度的数字焦虑,许多参与者依靠研究团队为他们设置技术。MCI患者在主动智能手机应用程序中的认知测试游戏中尤其困难,他们对自己的认知障碍有了更强的意识。由于熟悉且不影响外观,参与者更喜欢佩戴在手腕上而非头上的设备。虽然一些参与者喜欢使用可穿戴设备,但另一些人质疑其用于医疗目的的准确性。对于从可穿戴设备收集了哪些数据以及如何收集,也缺乏了解,一些人对数据披露表示担忧。有专业或护理职责的参与者描述了他们忙碌的生活方式如何阻碍了可穿戴设备的日常使用。

结论

这些发现凸显了采用包容性设计方法以满足用户需求并支持数字包容性的重要性,以及采用有效的沟通策略以提高透明度并减少对数据披露的担忧的重要性。未来需要开展研究,以探索实施当前建议以支持数字健康公平性的有效性,并与用户共同设计一种沟通策略,以确保信息易于理解。

试验注册

CODEC-II作为一项临床试验在ClinicalTrials.gov注册库中进行了回顾性注册(试验注册号:NCT07051408,注册日期:2025年6月3日)。

补充信息

在线版本包含可在10.1186/s44247-025-00191-3获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/dba5a8fad6da/44247_2025_191_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/b12a1b66b43e/44247_2025_191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/51f376e80c12/44247_2025_191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/c5f6d0fb9ecf/44247_2025_191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/dba5a8fad6da/44247_2025_191_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/b12a1b66b43e/44247_2025_191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/51f376e80c12/44247_2025_191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/c5f6d0fb9ecf/44247_2025_191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebad/12394386/dba5a8fad6da/44247_2025_191_Fig4_HTML.jpg

相似文献

1
Acceptability of wearable technology for the early detection of dementia-causing diseases: perspectives from the CODEC II cohort.可穿戴技术在痴呆症致病疾病早期检测中的可接受性:CODEC II队列研究的观点
BMC Digit Health. 2025;3(1):55. doi: 10.1186/s44247-025-00191-3. Epub 2025 Aug 29.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Technology-enabled CONTACT tracing in care homes in the COVID-19 pandemic: the CONTACT non-randomised mixed-methods feasibility study.新冠疫情期间养老院中基于技术的接触者追踪:CONTACT非随机混合方法可行性研究
Health Technol Assess. 2025 May;29(24):1-24. doi: 10.3310/UHDN6497.
4
A digital intervention to improve mental health and interpersonal resilience for young people who have experienced online sexual abuse: the i-Minds non-randomised feasibility clinical trial and nested qualitative study.一项针对遭受网络性虐待的年轻人改善心理健康和人际恢复力的数字干预措施:i-Minds非随机可行性临床试验及嵌套定性研究
Health Soc Care Deliv Res. 2025 Jul;13(28):1-27. doi: 10.3310/THAL8732.
5
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
6
Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.医护人员非正规使用手机和其他移动设备来支持工作:定性证据综合评价。
Cochrane Database Syst Rev. 2024 Aug 27;8(8):CD015705. doi: 10.1002/14651858.CD015705.pub2.
7
Feasibility, acceptability and appropriateness of laparoscopic versus abdominal hysterectomy for women and healthcare professionals: the LAVA trial qualitative process evaluation.腹腔镜子宫切除术与腹式子宫切除术对女性和医护人员的可行性、可接受性及适宜性:LAVA试验定性过程评估
Health Technol Assess. 2025 Jul 23:1-21. doi: 10.3310/GJTC1325.
8
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
9
OrthoticS for TReatment of symptomatic flat feet In CHildren (OSTRICH): a randomised controlled trial.儿童症状性扁平足治疗的矫形器(鸵鸟研究):一项随机对照试验
Health Technol Assess. 2025 Aug 6:1-49. doi: 10.3310/PLKJ4541.
10
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.

本文引用的文献

1
Enablers and barriers to engaging under-served groups in research: Survey of the United Kingdom research professional's views.让服务不足群体参与研究的促进因素和障碍:对英国研究专业人员观点的调查
NIHR Open Res. 2023 Dec 18;3:37. doi: 10.3310/nihropenres.13434.2. eCollection 2023.
2
Recommendations to advance digital health equity: a systematic review of qualitative studies.推进数字健康公平性的建议:定性研究的系统评价
NPJ Digit Med. 2024 Jun 29;7(1):173. doi: 10.1038/s41746-024-01177-7.
3
Trust in and Acceptance of Artificial Intelligence Applications in Medicine: Mixed Methods Study.
对人工智能在医学中的应用的信任和接受:混合方法研究。
JMIR Hum Factors. 2024 Jan 17;11:e47031. doi: 10.2196/47031.
4
Usability and acceptability of wearable technology in the early detection of dementia.可穿戴技术在痴呆症早期检测中的可用性和可接受性。
Alzheimers Dement. 2022 Dec;18 Suppl 2:e059820. doi: 10.1002/alz.059820.
5
Digital Engagement of Older Adults: Scoping Review.老年人的数字化参与:范围综述。
J Med Internet Res. 2022 Dec 7;24(12):e40192. doi: 10.2196/40192.
6
Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses.可穿戴活动追踪器对增加身体活动和改善健康的有效性:系统评价和荟萃分析的系统评价。
Lancet Digit Health. 2022 Aug;4(8):e615-e626. doi: 10.1016/S2589-7500(22)00111-X.
7
Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.淀粉样蛋白-β错误折叠和 GFAP 可预测 17 年内临床阿尔茨海默病诊断的风险。
Alzheimers Dement. 2023 Mar;19(3):1020-1028. doi: 10.1002/alz.12745. Epub 2022 Jul 19.
8
Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies.身体活动对痴呆和阿尔茨海默病的保护作用:队列和病例对照研究的系统评价、荟萃分析和质量评估。
Br J Sports Med. 2022 Jun;56(12):701-709. doi: 10.1136/bjsports-2021-104981. Epub 2022 Mar 17.
9
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
10
Using Digital Speech Assessments to Detect Early Signs of Cognitive Impairment.使用数字语音评估来检测认知障碍的早期迹象。
Front Digit Health. 2021 Oct 27;3:749758. doi: 10.3389/fdgth.2021.749758. eCollection 2021.